Experts are rapidly focused on retatrutide compounds , a novel dual agonist targeting both GLP-1 and GIP receptors. This unique strategy appears to offer considerable promise for weight management and associated health issues . Early clinical studies have shown promising results, indicating a potential change in how we manage excess weight and … Read More